J Urol. 2019 May 15:101097JU0000000000000336. doi: 10.1097/JU.0000000000000336
Zuniga KB1,2, Zhao S3, Kenfield SA3, Cedars B4, Cowan JE3, Van Blarigan EL3,5, Broering JM3, Carroll PR3, Chan JM3,5.
- Overview Prostate Cancer and Vitamin D
- Variety of Vitamin D forms treat Prostate Cancer – RCT Review April 2019
- Prostate Cancer death 40 percent less likely if 40 ng level of vitamin D – Meta-analysis Oct 2018
- Low-Grade Prostate Cancer 70 percent less likely to progress if good level of Omega-3 – June 2018
Increased use of Vitamin D
- Vitamin D very popular with Canadian seniors having complex medical problems – Jan 2019
- Vitamin D overtakes Vitamin C to become the UK's best-selling supplement – Jan 2019
- Vitamin D is perceived to be the healthiest food ingredient (more than fiber, whole grains, Omega-3, organic, etc) Survey May 2018
- Vitamin D is the most popular supplement, and was in the first commercial supplement – cod liver oil – May 2018
- Vitamin D was the most supplemented vitamin or mineral in the US - 2017
To explore prevalence and trends of self-reported complementary and alternative medicine (CAM) use among patients with prostate cancer (PCa) using the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURETM).
MATERIALS AND METHODS:
Between 1996-2016, 7,989 CaPSURE participants completed questionnaires on use of nearly 70 CAM types. Participants were defined as users if they ever indicated CAM use. To evaluate trends among patients with newly diagnosed PCa, we considered CAM use within 24 months of diagnosis and calculated percent change in CAM use between groups defined by year of diagnosis (n = 7,696).
Fifty-six percent of patients with PCa reported CAM use on at least one questionnaire. Multivitamin and omega-3 fatty acid use was common (40% and 24%, respectively). Compared to non-users, greater proportions of CAM users were college-educated, had a higher household income, and lived in the West and Midwest. Median prostate-specific antigen (PSA) at diagnosis was 5.8 (IQR 4.4-8.4) among users and 6.2 (IQR 4.7-10.1) among non-users (p < 0.01). Between those diagnosed in 1996-2000 and 2011-2016, CAM use increased +128% (24% to 54%). Comparing participants diagnosed in 2006-2010 and 2011-2016, a large increase was seen in supplemental vitamin D (+108%) and a large decrease was seen in supplemental vitamin E (-48%) use.
Many patients with PCa reported CAM use. Multivitamins and omega-3 fatty acids were commonly used, and Vitamin D use increased dramatically from 2006-2010 to 2011-2016. These data can guide clinical discussions and decision-making, such as nutritionist referral, and help prioritize future research.